Swine Fever Vaccine Market Synopsis

Swine Fever Vaccine Market Size is Valued at USD 3.02 Billion in 2023 and is Projected to Reach USD 4.78 Billion by 2032, Growing at a CAGR of 5.90% From 2024-2032.

The Swine Fever Vaccine Market can be defined as the industry associated with the creation, manufacturing, and sale of vaccines for preventing or curing swine fever with a special focus on African swine fever (ASF) and classical swine fever (CSF). These vaccines are important for prevention of viral diseases affecting swine and which are economically disastrous in the pork production. Due to the growing global concern in food consumption, pork demands, and the proper health management of the livestock’s vaccines have therefore become crucial.

• The Swine Fever Vaccine Market has numerous influential factors, but more importantly, there has been several outbreaks of swine fever all around the world. As a result of increase in cases of ASF and CSF, there has been high mortality rates in pigs hence governments and farmers have decided to go for immunization. The deadly disease easily transmitted and is threatening the food chains making it mandatory to have vaccines hence increasing pressure for research and Development to come up with vaccines.
• Also, the increasing consciousness middle farmers and livestock owners about the financial advantages of the vaccines also drive the market. Based on the findings it can be concluded that vaccination reduces production losses likely to occur due to disease incidence hence leading to improved stock health and production. Veterinary healthcare continues to grow to add more opportunities and possibilities in the market through the introduction of new technologies to advance vaccination services to swine producers.

Swine Fever Vaccine Market Trend Analysis

The increasing adoption of advanced vaccine technologies.

• The prominent trend in the Swine Fever Vaccine Market is that there is consistent movement towards enhanced vaccine platforms like DNA and mRNA. Such approaches are more effective, safe and stable than traditional methods, which increases acceptance of the products among veterinarians and farmers. Also on the rise is individual veterinary medicine where vaccines are given according to the condition on the farm and diseases prevalent on the area of concern.
• Another major factor that are leading to this is increased M&A activities that are making the vaccine manufacturers to consolidate and make the competitions stiff. Market leaders are devising strategies to increase their R & D capabilities to produce the right mix of products to satisfy swine producers. Sustainability and exploitation of green production practices are also creating the future market, as consumers demand timely responsible sourcing.

Emerging economies where the livestock sector is expanding rapidly.

• The Market for Swine Fever Vaccine is still full of several potential for development since most of the countries around the region are still experiencing growth in their livestock industries. The vaccine manufacturers could enter these markets given that countries like China, Vietnam as well as Brazil are ramping up production of pork in line with the escalating demand both domestically as well as in the international market. Fulfiling proper and efficient vaccination programs shall further improve the health and production of these herds which will pave the way on forming partnerships with farmers and governments from these areas.
• In addition, biotechnology and research improvements may cause new formulation of vaccines and new methods of delivering vaccines open up more opportunities for the market players. As it relates to selection, the possibilities of developing vaccines which target multiple diseases simultaneously may appeal to stocking manufacturers interested in minimizing their vaccination schedules. Working joint research and clinical trials can improve innovation for the next vaccine product, which would guarantee growth in the Swine Fever Vaccine Market.

Swine Fever Vaccine Market Segment Analysis:

• Swine Fever Vaccine Market Segmented on the basis of type, Technology, application, and end-users.

By Type, Inactivated Vaccines segment is expected to dominate the market during the forecast period

• The swine fever vaccine market is primarily categorized into three types: , and these are the inactivated vaccines, the live attenuated vaccines and the subunit vaccines. Both types of vaccines have their advantages, used in swine populations, inactivated vaccines contain dead pathogens so they are harmless and will not cause the disease. Lev attenuated vaccines contain actual controlled and weakened virus capable of replication and providing immunity as well as long lasting immunity though handling is restrictive with a correct method of administration to avoid disease. Subunit vaccines only contain subfractions of the virus like proteins in order to prevent the use of the virus for the pig’s safety but effective enough to fight against swine fever. Effectiveness, safety, and the requirements eventually dictate how each type is used in regard to swine producers.

By Application, Prevention segment held the largest share in 2024

• In the swine fever vaccine market, the application is classified into two, namely prevention and treatment. Previous vaccines are mainly used to vaccinate pigs against swine fever viruses before exposure in an attempt to achieve herd immunity and thus few cases of breakout. These vaccines are essential in sustaining bench strength for the swine population and controlling on expenses due to diseases. Treatment vaccines are not very common but they are developed to be given after the disease has attacked the body with the intention of reducing the severity of the disease, and to assist in healing. These vaccines can be useful in controlling outbreaks most especially in conditions that require quick action to save the lives of affected animals and prevent further spread of the virus across groups of animals in the affected farms.

Swine Fever Vaccine Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• The Asia Pacific region is the leading market for Swine Fever Vaccine Market because of increased pig farming and the tremendous effect of swine fever in countries such as China, Vietnam, and the Philippines. This region is amongst the largest producers of pork in the world hence farmers there need to ensure proper immunization procedures. Consumer awareness about prevention and cure of those diseases as well as government support for disease prevention measures and vaccination also fortify this market in the region.
• Further, there has been high economic growth in Asia Pacific, which has improved on investment in vaccination infrastructure in the veterinary segment. The increasing incidences of disease awareness among animal owners also influence the need for swine fever vaccines. Therefore, Asia Pacific is expected to retain its position in the leadership position in the market due to the increasing pork consumption and the importance of pervasive management approaches to diseases.

Active Key Players in the Swine Fever Vaccine Market

• Zoetis Inc. (United States)
• Boehringer Ingelheim (Germany)
• Merck Animal Health (United States)
• Elanco Animal Health (United States)
• Vetoquinol S.A. (France)
• Ceva Santé Animale (France)
• Hipra (Spain)
• Valneva SE (France)
• Wuxi Zoetis Biological Products Co., Ltd. (China)
• Daiichi Sankyo Co., Ltd. (Japan)
• Others

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Swine Fever Vaccine Market by Type
 4.1 Swine Fever Vaccine Market Snapshot and Growth Engine
 4.2 Swine Fever Vaccine Market Overview
 4.3 Inactivated Vaccines
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Inactivated Vaccines: Geographic Segmentation Analysis
 4.4 Live Attenuated Vaccines
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Live Attenuated Vaccines: Geographic Segmentation Analysis
 4.5 Subunit Vaccines
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Subunit Vaccines: Geographic Segmentation Analysis

Chapter 5: Swine Fever Vaccine Market by Technology
 5.1 Swine Fever Vaccine Market Snapshot and Growth Engine
 5.2 Swine Fever Vaccine Market Overview
 5.3 Conventional Vaccines
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Conventional Vaccines: Geographic Segmentation Analysis
 5.4 DNA Vaccines
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 DNA Vaccines: Geographic Segmentation Analysis
 5.5 mRNA Vaccines
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 mRNA Vaccines: Geographic Segmentation Analysis

Chapter 6: Swine Fever Vaccine Market by Application
 6.1 Swine Fever Vaccine Market Snapshot and Growth Engine
 6.2 Swine Fever Vaccine Market Overview
 6.3 Prevention
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Prevention: Geographic Segmentation Analysis
 6.4 Treatment
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Treatment: Geographic Segmentation Analysis

Chapter 7: Swine Fever Vaccine Market by End-User
 7.1 Swine Fever Vaccine Market Snapshot and Growth Engine
 7.2 Swine Fever Vaccine Market Overview
 7.3 Veterinary Clinics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Veterinary Clinics: Geographic Segmentation Analysis
 7.4 Research Laboratories
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Research Laboratories: Geographic Segmentation Analysis
 7.5 Farm Owners
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Farm Owners: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Swine Fever Vaccine Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 ZOETIS INC (UNITED STATES)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 BOEHRINGER INGELHEIM (GERMANY)
 8.4 MERCK ANIMAL HEALTH (UNITED STATES)
 8.5 ELANCO ANIMAL HEALTH (UNITED STATES)
 8.6 VETOQUINOL S A (FRANCE)
 8.7 CEVA SANTÉ ANIMALE (FRANCE)
 8.8 HIPRA (SPAIN)
 8.9 VALNEVA SE (FRANCE)
 8.10 WUXI ZOETIS BIOLOGICAL PRODUCTS CO LTD (CHINA)
 8.11 DAIICHI SANKYO CO LTD. (JAPAN)
 8.12 OTHER MAJOR PLAYERS

Chapter 9: Global Swine Fever Vaccine Market By Region
 9.1 Overview
 9.2. North America Swine Fever Vaccine Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Type
  9.2.4.1 Inactivated Vaccines
  9.2.4.2 Live Attenuated Vaccines
  9.2.4.3 Subunit Vaccines
  9.2.5 Historic and Forecasted Market Size By Technology
  9.2.5.1 Conventional Vaccines
  9.2.5.2 DNA Vaccines
  9.2.5.3 mRNA Vaccines
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Prevention
  9.2.6.2 Treatment
  9.2.7 Historic and Forecasted Market Size By End-User
  9.2.7.1 Veterinary Clinics
  9.2.7.2 Research Laboratories
  9.2.7.3 Farm Owners
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Swine Fever Vaccine Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Type
  9.3.4.1 Inactivated Vaccines
  9.3.4.2 Live Attenuated Vaccines
  9.3.4.3 Subunit Vaccines
  9.3.5 Historic and Forecasted Market Size By Technology
  9.3.5.1 Conventional Vaccines
  9.3.5.2 DNA Vaccines
  9.3.5.3 mRNA Vaccines
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Prevention
  9.3.6.2 Treatment
  9.3.7 Historic and Forecasted Market Size By End-User
  9.3.7.1 Veterinary Clinics
  9.3.7.2 Research Laboratories
  9.3.7.3 Farm Owners
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Bulgaria
  9.3.8.2 The Czech Republic
  9.3.8.3 Hungary
  9.3.8.4 Poland
  9.3.8.5 Romania
  9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Swine Fever Vaccine Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Type
  9.4.4.1 Inactivated Vaccines
  9.4.4.2 Live Attenuated Vaccines
  9.4.4.3 Subunit Vaccines
  9.4.5 Historic and Forecasted Market Size By Technology
  9.4.5.1 Conventional Vaccines
  9.4.5.2 DNA Vaccines
  9.4.5.3 mRNA Vaccines
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Prevention
  9.4.6.2 Treatment
  9.4.7 Historic and Forecasted Market Size By End-User
  9.4.7.1 Veterinary Clinics
  9.4.7.2 Research Laboratories
  9.4.7.3 Farm Owners
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 Netherlands
  9.4.8.5 Italy
  9.4.8.6 Russia
  9.4.8.7 Spain
  9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Swine Fever Vaccine Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Type
  9.5.4.1 Inactivated Vaccines
  9.5.4.2 Live Attenuated Vaccines
  9.5.4.3 Subunit Vaccines
  9.5.5 Historic and Forecasted Market Size By Technology
  9.5.5.1 Conventional Vaccines
  9.5.5.2 DNA Vaccines
  9.5.5.3 mRNA Vaccines
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Prevention
  9.5.6.2 Treatment
  9.5.7 Historic and Forecasted Market Size By End-User
  9.5.7.1 Veterinary Clinics
  9.5.7.2 Research Laboratories
  9.5.7.3 Farm Owners
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Swine Fever Vaccine Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Type
  9.6.4.1 Inactivated Vaccines
  9.6.4.2 Live Attenuated Vaccines
  9.6.4.3 Subunit Vaccines
  9.6.5 Historic and Forecasted Market Size By Technology
  9.6.5.1 Conventional Vaccines
  9.6.5.2 DNA Vaccines
  9.6.5.3 mRNA Vaccines
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Prevention
  9.6.6.2 Treatment
  9.6.7 Historic and Forecasted Market Size By End-User
  9.6.7.1 Veterinary Clinics
  9.6.7.2 Research Laboratories
  9.6.7.3 Farm Owners
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkey
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Swine Fever Vaccine Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Type
  9.7.4.1 Inactivated Vaccines
  9.7.4.2 Live Attenuated Vaccines
  9.7.4.3 Subunit Vaccines
  9.7.5 Historic and Forecasted Market Size By Technology
  9.7.5.1 Conventional Vaccines
  9.7.5.2 DNA Vaccines
  9.7.5.3 mRNA Vaccines
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Prevention
  9.7.6.2 Treatment
  9.7.7 Historic and Forecasted Market Size By End-User
  9.7.7.1 Veterinary Clinics
  9.7.7.2 Research Laboratories
  9.7.7.3 Farm Owners
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research